N2-(1-Oxotetradecyl)-L-lysyl-L-alanyl-L-lysyl-L-alaninamide, 97%, 100mg

Ethyl 2,4,6-Trimethylbenzoate>95.0%(GC)25g

6-(1,1-dimethylpropyl)-1-benzothiophene-3-carboxylic acid, 95.0%, 1g

tert-Butyl (trans-4-hydroxy-1-methylcyclohexyl)carbamate, 95.0%, 1g

5-(1H-Imidazol-1-yl)-2-pyridinamine, 95%, 5g

4-Bromo-5-fluoro-2-methylaniline, 97.0%, 1g

Carbonate de manganèse(II), min 44% Mn, pa, 250 g, emballage plastique.

1-N-Benzyl-3-hydroxy-piperidine, 98.0%, 1g

DL-Homophenylalanine>97.0%(HPLC)(T)5g

1-((2,3,5,6-tetramethylphenyl)sulfonamido)cyclohexane-1-carboxylic acid, 95.0%, 250mg

3,3',5,5'-Tetramethyl-1H,1'H-4,4'-bipyrazole, 95.0%, 1g

2,3,4,6-Tetra-O-acetyl-beta-D-glucopyranosyl Isothiocyanate [for HPLC Labeling]>98.0%(HPLC)(N)1g

Tert-butyl 2-methyl-2,3,4,5-tetrahydro-1h-1,5-benzodiazepine-1-carboxylate, 95%, 100mg